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Mutations in Tbr1, a high-confidence ASD (autism spectrum disorder)-risk gene
encoding the transcriptional regulator TBR1, have been shown to induce diverse
ASD-related molecular, synaptic, neuronal, and behavioral dysfunctions in mice.
However, whether Tbr1 mutations derived from autistic individuals cause similar
dysfunctions in mice remains unclear. Here we generated and characterized mice
carrying the TBR1-K228E de novo mutation identified in human ASD and identified
various ASD-related phenotypes. In heterozygous mice carrying this mutation
(Tbr1+/K228E mice), levels of the TBR1-K228E protein, which is unable to bind target
DNA, were strongly increased. RNA-Seq analysis of the Tbr1+/K228E embryonic brain
indicated significant changes in the expression of genes associated with neurons,
astrocytes, ribosomes, neuronal synapses, and ASD risk. The Tbr1+/K228E neocortex
also displayed an abnormal distribution of parvalbumin-positive interneurons, with a
lower density in superficial layers but a higher density in deep layers. These changes
were associated with an increase in inhibitory synaptic transmission in layer 6 pyramidal
neurons that was resistant to compensation by network activity. Behaviorally, Tbr1+/K228E
mice showed decreased social interaction, increased self-grooming, and modestly
increased anxiety-like behaviors. These results suggest that the human heterozygous
TBR1-K228E mutation induces ASD-related transcriptomic, protein, neuronal, synaptic,
and behavioral dysfunctions in mice.
Keywords: autism spectrum disorder, Tbr1, transcription factor, cortical development, GABAergic neurons,
synaptic transmission, social and repetitive behavior
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INTRODUCTION
Autism spectrum disorders (ASD) are brain developmental
disorders characterized by social deficits and repetitive behaviors.
A large number of genetic mutations associated with ASD have
been identified (Rosti et al., 2014; De Rubeis and Buxbaum,
2015; de la Torre-Ubieta et al., 2016; McDermott et al.,
2018), and potential mechanisms underlying ASD have been
identified (Südhof, 2008; Bourgeron, 2009, 2015; Kleijer et al.,
2014; Barak and Feng, 2016; Hulbert and Jiang, 2016; Golden
et al., 2018). However, knock-in animals carrying heterozygous
ASD-risk mutations from individuals with ASD have been less
thoroughly investigated.
TBR1, a neuron-specific T-box transcription factor, regulates
the regional and laminar identity of neocortical regions,
including layer 6, in the developing brain (Bulfone et al., 1995,
1998; Dwyer and O’Leary, 2001; Hevner et al., 2001, 2002;
Englund et al., 2005; Kolk et al., 2006; Bayatti et al., 2008; Bedogni
et al., 2010; Han et al., 2011; McKenna et al., 2011; Cánovas et al.,
2015; Marinaro et al., 2017; Elsen et al., 2018; Liu et al., 2018).
Neuronal activation upregulates the expression of Tbr1, which
together with CASK, a synaptic PDZ protein that can translocate
into the nucleus, and CINAP, a nucleosome assembly protein,
form a complex that regulates the expression of target proteins,
including reelin and the GluN2B subunit of N-methyl-D-
aspartate receptor (NMDAR), involved in the regulation of brain
development and function (Hsueh et al., 2000; Wang G. S. et al.,
2004; Wang T. F. et al., 2004; Chuang et al., 2014; Huang et al.,
2014; Klionsky et al., 2016). More recently, TBR1 was found to
directly interact with FOXP2 (Sakai et al., 2011; Deriziotis et al.,
2014), a transcription factor associated with brain development
and speech, as well as language impairments (Enard et al., 2002;
Fisher and Scharff, 2009; Enard, 2011; Tsui et al., 2013).
Reflecting this critical role of TBR1 in brain and cortical
development, TBR1 has been strongly associated with brain
disorders, including ASD and intellectual disability (Neale et al.,
2012; O’Roak et al., 2012, 2014; Traylor et al., 2012; De Rubeis
et al., 2014; Deriziotis et al., 2014; Hamdan et al., 2014; Palumbo
et al., 2014; Chuang et al., 2015; Sanders et al., 2015; Bowling
et al., 2017; Geisheker et al., 2017; McDermott et al., 2018; Vegas
et al., 2018); among the many other genes on the SFARI (Simons
Foundation Autism Research Initiative) list, it is considered a
category 1 high-confidence ASD-risk gene (Abrahams et al.,
2013). In addition, TBR1 has been shown to regulate the
expression of various ASD-risk genes (Chuang et al., 2014, 2015;
Huang et al., 2014; Notwell et al., 2016; Fazel Darbandi et al.,
2018), likely as part of a large network of genes involved in ASD.
More recently, a multitude of neurobiological mechanisms
that may underlie TBR1-dependent development of ASD have
been reported in studies using Tbr1-mutant mice (Huang
and Hsueh, 2015). Specifically, a Tbr1 haploinsufficiency has
been shown to diminish amygdalar projections and induce
autism-like behaviors (including reduced social interaction,
cognitive inflexibility and impaired associative memory) that
can be corrected by direct and indirect activation of NMDARs
(Huang et al., 2014; Lee et al., 2015). In addition, layer
6-specific deletion of TBR1 leads to the loss of excitatory
and inhibitory synapses in layer 6 pyramidal neurons, and
anxiety-like and aggressive behaviors (Fazel Darbandi et al.,
2018). A Tbr1 haploinsufficiency also induces impairments
in olfactory discrimination (but not olfactory sensation) that
are improved by NMDAR activation (Huang et al., 2019).
Although these results provide significant insights into how
TBR1 dysfunctions lead to ASD, whether and how TBR1
mutations identified in humans lead to ASD remains unclear.
Here, we generated and characterized a knock-in mouse line
carrying the TBR1-K228E mutation identified in a 7-year-old
male with ASD (O’Roak et al., 2012). This mutation, localized
to the TBR1 protein T-box domain involved in DNA binding
and protein-protein interaction, has been shown to disrupt the
interaction between TBR1 and FOXP2 (Deriziotis et al., 2014),
without affecting TBR1 nuclear localization, homodimerization,
CASK interaction, or transcriptional-repression activity. These
experiments, performed in HEK293 cells, suggested however
that a portion of TBR1-K228E protein targeted to the nucleus
form abnormal aggregates in heterologous cells (Deriziotis et al.,
2014). Although these findings provide important clues as to
the potential pathophysiology of the TBR1-K228E mutation,
whether mice carrying a heterozygous TBR1-K228E mutation
(Tbr1+/K228E mice) display ASD-related behaviors and related
molecular and cellular abnormalities remain unknown. We
report here that Tbr1+/K228E mice show a multitude of
ASD-related phenotypes at protein, transcriptomic, cellular,
synaptic and behavioral levels, findings that differ in certain
aspects from previous results obtained in mice carrying a null
allele or layer 6-specific deletion of Tbr1.
MATERIALS AND METHODS
Animals
Floxed TBR1-K228E mice in a C57BL/6J background carrying
a knock-in mutation of Tbr1 (K228E) in exon 1 of the
Tbr1 gene flanked by loxP sites and a neomycin cassette
(Tbr1K228Ecassette/+) were designed and generated by
Cyagen. The neomycin cassette was removed by crossing
Tbr1K228Ecassette/+ mice with protamine-Cre mice (C57BL/6J).
WT, Tbr1+/K228E, and Tbr1K228E/K228E mice were genotyped by
PCR using the following primers, 5′-TTTTGGAAAAGGGGAA
TGTG-3′ (forward), 5′-GGAGAAGGGAAGACGTAGGG-3′
(reverse). Animals were housed under a 12-h (13:00–01:00)
dark/light cycle and were fed ad libitum. The animal study was
reviewed and approved by the Committee of Animal Research
at Korea Advanced Institute for Science and Technology
(KAIST; KA2016-30).
Structural Modeling of TBR1 and Solubility
Prediction
The homology model of TBR1 was built based on the crystal
structure of TBX5 (PDB ID: 2X6U) using the SWISS model
server (Waterhouse et al., 2018). The DNA-bound form of
TBR1 was then constructed by superimposing a homology
model of TBR1 onto the crystal structure of TBX3 in complex
with DNA (PDB ID 1H6F). The missense mutations, p.K228E
and p.N374H, of TBR1 were introduced using a point mutation
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function in PyMOL software (The PyMOL Molecular Graphics
System, version 1.2 r3pre, Schrödinger, LLC), after which
energy minimization was performed using Modeler software
(Fiser et al., 2000). The stability of TBR1 variants K228E and
N374H was predicted by calculating ∆∆G (∆GWT−∆Gmut)
using the DynaMut web server (Rodrigues et al., 2018).
All represented structural figures were generated using
PyMOL software.
Protein Expression and Purification
The DNA binding T-box domain (DBD) of the human
TBR1 protein with WT sequence (hTBR1DBD; 200–400 aa)
was subcloned into pET28a vector (Novagen) with
enzyme sites, NdeI and HindIII. The K228E point
mutation was introduced using the following PCR primers:
5′-ATGATCATCACTGAACAGGGAAGGCGCATGTTT-
3′ and 5′- AAACATGCGCCTTCCCTGTTCAGTGATGAT
CAT-3′. The N374H point mutation was introduced using
the following PCR primers: 5′-ACCGCCTACCAGCACACG
GATATTACACAACTA-3′ and 5′-TAGTTGTGTAATATCC
GTGTGCTGGTAGGCGGT-3′. The hTBR1DBD constructs
(WT, K228E, and N374H) transformed in E. coli BL21(DE3;
Enzynomics) were cultured in Luria-Bertani (LB) media with
30 µg/ml kanamycin at 37◦C until OD600 reached 0.8, and then
the expression of the hTBR1DBD protein was induced by the
addition of 0.5 mM isopropyl-β-D-thiogalactoside (IPTG) at
18◦C for 16 h. The cultured and harvested cells were ruptured
in lysis buffer [20 mM Tirs-HCl pH 7.5, 500 mM NaCl, 5%
glycerol, 2 mM β-mercaptoethanol, 30 mM imidazole, and
1 mM phenylmethanesulfonyl fluoride (PMSF)] by sonication
and the soluble fractions were collected by centrifuging cell
lysate at 20,000 rpm for an hour. The supernatant was loaded
to a Ni-NTA column (GE healthcare), which was equilibrated
with binding buffer (50 mM Tris-HCl pH 7.5, 500 mM NaCl,
5% glycerol, 30 mM imidazole, and 2 mM β-mercaptoethanol)
and hTBR1DBD proteins (WT, K228E, and N374H) were eluted
with binding buffer solution containing 250 mM imidazole. The
amino terminal hexa-histidine tag was removed by thrombin
treatment. The hTBR1DBD proteins lacking the hexa-histidine
tag were then further purified using S column (GE healthcare).
Fractions containing hTBR1DBD proteins were collected and the
buffer was changed against the final buffer (20 mM HEPES pH
7.5, 150 mM NaCl, and 5 mM MgCl2) using PD-10 desalting
column (GE healthcare).
Circular Dichroism (CD) for Secondary
Structural Comparison
The secondary structures of purified hTBR1DBD proteins (WT,
K228E, and N374H) were monitored by circular dichroism (CD)
at 25◦C in 1mm cell. The hTBR1DBD protein at the concentration
of 150 µM in final buffer (20 mMHEPES pH 7.5, 150 mMNaCl,
and 5 mM MgCl2) was monitored. CD spectra were recorded
using a Jasco J-815 CD spectrometer between 190 and 230 nm at
1-nm intervals averaged over 1 s. The molar ellipticity ([θ]molar)




deg × cm2 × dmol−1
where, θobs is the observed value of CD, d is distance of
measuring cell andm is molar concentration of the protein.
Biolayer Interferometry (BLI)
The oligodexoynucleotides (ODNs) of 5′- biotin- TATATA
GGTTGAGTGGCACGTTCCTGGGTGTGAGACC-3′ and
5′- GGTCTCACACCCAGGAACGTGCCACTCAA -3′ were
purchased (Macrogen) and annealed in the final buffer. Prior
to experiments, all streptavidin biosensors (Fortebio, USA)
were hydrated in distilled water at 25◦C for 10 min. To avoid
buffer effects, the hydrated biosensors were then incubated in
kinetic buffer (20 mM HEPES pH 7.5, 100 mM NaCl) at 25◦C
for 5 min, which showed stable signals. Annealed biotinylated
ODNs (10 µM) were immobilized on streptavidin biosensor in
kinetic buffer solution for 120 s. The initial baselines were then
recorded in a fresh kinetic buffer for 60 s. The association and
dissociation sensorgrams of hTBR1DBD WT at concentrations
ranging from 2.5 µM to 10 µM were monitored for 120 s each
as a positive control by using biolayer interferometry (BLI),
BLITZ system (ForteBio, USA). Then, the binding kinetics
of hTBR1DBD mutants (K228E and N374H). The equilibrium
binding constant (Kd), association rate constant (kon), and
dissociation rate constant (koff) were determined from the BLI
data at various concentrations of the hTBR1DBD protein using
the global fitting method provided in data analysis software
version 7.0 (Fortebio).
RNA-Seq Library Preparation and
Sequencing
Mouse brains were immersed in RNAlater solution (Ambion,
AM7020) to stabilize RNA. RNA extraction, library preparation,
and sequencing were performed by Macrogen Incorporation
(Seoul, South Korea). RNA samples for sequencing were
prepared using a TruSeq RNA Sample Prep Kit v2 (Illumina)
according to the manufacturer’s instructions. An Illumina’s
HiSeq 4000 were used for sequencing to generate 101-bp
paired-end reads. Raw data were submitted to the GEO
(Gene Expression Omnibus) repository under accession
number GSE134526.
RNA-Seq Analysis
Transcript abundance was estimated with Salmon (v0.11.2;
Patro et al., 2017) in Quasi-mapping-based mode onto the
Mus musculus genome (GRCm38) with GC bias correction
(--gcBias). Quantified gene-level abundance data was imported
to R (v.3.5.3) with the tximport (Soneson et al., 2015) package
and differential gene expression analysis was carried out using
R/Bioconductor DEseq2 (v1.22.2; Love et al., 2014). Normalized
read counts were computed by dividing the raw read counts
by size factors and fitted to a negative binomial distribution.
The P-values were first corrected by applying an empirical
estimation of the null distribution using the R fdrtool (v.1.2.15)
package and then adjusted for multiple testing with the
Benjamini–Hochberg correction. Genes with an adjusted P-value
of less than 0.05 were considered as differentially expressed.
Volcano plots were generated using the R ggplot2 (v.3.1.1)
package. The Gene Ontology (GO) enrichment analyses were
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performed using DAVID software (version 6.8; Huang da et al.,
2009). Mouse gene names were converted to human homologs
using the Mouse Genome Informatics (MGI) database1. Gene
Set Enrichment Analysis (GSEA2, Subramanian et al., 2005)
was used to determine whether a priori-defined gene sets
would show statistically significant differences in expression
between WT and Tbr1 mutant mice. Enrichment analysis was
performed using GSEAPreranked (gsea-3.0.jar) module on gene
set collections downloaded from Molecular Signature Database
(MSigDB) v6.13. GSEAPreranked was applied using the list of
all genes expressed, ranked by the fold change and multiplied
by the inverse of the P-value with recommended default settings
(1,000 permutations and a classic scoring scheme). The False
Discovery Rate (FDR) was estimated to control the false positive
finding of a given Normalized Enrichment Score (NES) by
comparing the tails of the observed and null distributions derived
from 1,000 gene set permutations. The gene sets with an FDR of
less than 0.05 were considered as significantly enriched.
qRT-PCR
RNA samples were reverse-transcribed using M-MLV cDNA
Synthesis kit (Enzynomics, EZ006S) with random hexamer
as primers. Synthesized cDNAs were diluted by 5-fold with
distilled water and subjected to qPCR reaction using HiPi
Real-Time PCR 2x Master Mix (Elpis Bio, EBT-1802) and
the following primers: LMBRD1, 5′-CGCCCCTTTAACCT
TTAGGCTG-3′ (forward), 5′-AAAGGCCAAAATAGCCAGGA
GC-3′ (reverse); ILK, 5′-CTCCCAGTGCTAGGTGCTTG-3′
(forward), 5′-GGTCCACAACGAAATTGGTGC-3′ (reverse);
LYPD6, 5′-CATCCCGGGTGCCAGTTCTC-3′ (forward), 5′-
GCGTGTCACTCATACAGAGGG-3′ (reverse); PDE3B, 5′-AC
TTCACAAGGGATTGAGTGGC-3′ (forward), 5′-GACCTCTT
ACCACTGCTGCG-3′ (reverse); CRX, 5′-CATCCAGGAGAG
TCCCCATTTC-3′ (forward), 5′-TGCTTCCTAGGGGCACTT
GAG-3′ (reverse); TBR1, 5′-TGCACGTGGTGGAAGTGAAT-
3′ (forward), 5′-CAGCCCGTGTAGATCGTGTC-3′ (reverse);
WNT7B, 5′-GCGTGGTCCTACCGCAG-3′ (forward), 5′-GACA
ATGCTCCGAGCTTCACG-3′ (reverse); RELN, 5′-CAAGCT
CAGCGGGTGTCTTA-3′ (forward), 5′-TGCTTACTAGGACG
ACCTCCAC-3′ (reverse); ADAMTS3, 5′-AAACTTGGGAAG
ACGAGAGGC-3′ (forward), 5′-AAGGTCCGTGACTTGGCT
TC-3′ (reverse); LRPAP1, 5′-ACATCAAGAGCGACACCCTG-
3′ (forward), 5′-GGGGCTCTTCAAACTCAGTGG-3′ (reverse);
NDNF, 5′-GCTTTTTCCGCACCACACAC-3′ (forward), 5′-CA
CCAGTAGAACAGCTCCATCCTTA-3′ (reverse); GAPDH, 5′-
TCACCACCATGGAGAAGGC-3′ (forward), 5′-GCTAAGCA
GTTGGTGGTGCA-3′ (reverse). cDNA templates in qPCR
mixture were quantified using BioRad CFX96 Real-Time PCR
Detection System (BioRad) with Delta-Delta Ct method in which
GAPDH was used as a reference.
Western Blotting
Whole-brain preparations from WT and Tbr1+/K228E mice at




using ultrasonicator. Antibodies for immunoblot assays were
purchased from commercial sources; TBR1 (Abcam; ab31940);
α-tubulin (Sigma Aldrich, T9026).
Brain Slices for Electrophysiology
For electrophysiology experiments, acute coronal brain slices
(300 µm thickness) of WT and Tbr1+/K228E mice were obtained
using a Vibratome (Leica VT1200) after anesthetizing animals
with isoflurane (Terrell solution, Piramal healthcare). Brains
were extracted and sliced in ice-cold dissection buffer containing
(in mM) 212 sucrose, 25 NaHCO3, 5 KCl, 1.25 NaH2PO4,
0.5 CaCl2, 3.5 MgSO4, 10 D-glucose, 1.25 L-ascorbic acid,
and 2 Na-pyruvate bubbled with 95% O2/5% CO2. The
slices were transferred to a recovery chamber at 32◦C with
normal ACSF (artificial cerebrospinal fluid; in mM: 125 NaCl,
2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 10 glucose, 2.5 CaCl2,
and 1.3 MgCl2, oxygenated with 95% O2/5% CO2). After
30-min recovery at 32◦C, slices were recovered for additional
30 min at 20–25◦C. For the recording, a single slice was
transferred to a submerged-type chamber at 27–28◦C with
circulating ACSF (2 ml/min) saturated with 95% O2 and
5% CO2. Recording pipettes were pulled from thin-walled
borosilicate glass capillaries (No. 30-0065, Harvard Apparatus)
with resistance 2.5–4.0 MΩ using a micropipette electrode puller
(PC-10, Narishige).
Whole-Cell Patch-Clamp Recording
Whole-cell patch-clamp recordings of mPFC layer 6 pyramidal
neurons were made using a MultiClamp 700B amplifier
(Molecular Devices) and Digidata 1550 (Molecular Devices).
During whole-cell patch-clamp recordings, series resistance was
monitored for each sweep by measuring the peak amplitude of
the capacitance currents in response to short hyperpolarizing
step pulse (5 mV, 40 ms). For all electrophysiological
measurements described below, layer 6 pyramidal neuron
in the prelimbic region of the mPFC were used. Histologically,
the pia-to-corpus callosum distance in this region was around
1,500 µm. The cortical region approximately 900–1,200 µm
away from pia were used for recordings. After cell rupturing,
cells with membrane capacitance larger than 100 were
selectively used because a small capacitance is a signature
for GABAergic cells.
To measure the intrinsic excitability of mPFC layer
6 pyramidal neurons, recording pipettes (2.5–3.5 MΩ) were
filled with an internal solution containing (in mM) 137 K-
gluconate, 5 KCl, 10 HEPES, 0.2 EGTA, 10 Na-phosphocreatine,
4 Mg-ATP, and 0.5 Na-GTP, with pH 7.2, 280 mOsm.
To measure inhibitory postsynaptic responses, picrotoxin
(100 µM), NBQX (10 µM) and D-AP5 (50 µM) were added.
After rupturing the cell, currents were clamped, and resting
membrane potential (RMP) was measured. Cells with RMP
larger than −55 mV were discarded. After stabilizing the
cells, RMP was adjusted by −70 mV. To measure the input
resistance, hyperpolarizing current steps (1-s duration, 0 to
−20 pA,−10 pA step increments) were injected into the patched
neurons. To measure the action potential (AP) threshold, a
series of current steps (2 ms duration at 2.5 Hz, 0–2,500 pA
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range, +10 pA increments) were injected until an AP was
generated. To obtain the sustained firing rate, a series of current
(1-s duration, 0 to +500 pA, +50 pA step increments) were
injected. After all measurements, the normal conditions of
recorded cells were confirmed by returning to the voltage-clamp
mode. In case Ra was >20 in this step, the acquired data was
not used.
To measure miniature excitatory postsynaptic currents
(mEPSCs) in mPFC layer 6 pyramidal neurons, recording
pipettes (3.0–4.0 MΩ) were filled with an internal solution
containing (in mM) 100 CsMeSO4, 10 TEA-Cl, 8 NaCl,
10 HEPES, 5 QX-314-Cl, 2 Mg-ATP, 0.3 Na-GTP, and 10 EGTA,
with pH 7.25, 295 mOsm. Whole-cell recordings of mEPSCs
were made in neurons kept at the holding potential of −70 mV.
TTX (1 µM) and picrotoxin (100 µM) were added to ACSF
to inhibit spontaneous AP-mediated synaptic currents and
inhibitory postsynaptic currents (IPSCs), respectively.
For miniature inhibitory postsynaptic currents (mIPSCs)
measurements in mPFC layer 6 pyramidal neurons, recording
pipettes (3.0–4.0 MΩ) were filled with an internal solution
containing (in mM) 120 CsCl, 10 TEA-Cl, 8 NaCl, 10 HEPES,
5 QX-314-Cl, 4 Mg-ATP, 0.3 Na-GTP and 10 EGTA, with
pH 7.35, 280 mOsm. TTX (1 µM), NBQX (10 µM) and
D-AP5 (50 µM) were added to ACSF to inhibit spontaneous
AP-mediated synaptic currents, AMPAR-mediated currents, and
NMDAR-mediated currents, respectively.
For sequential recording of spontaneous EPSCs (sEPSCs)
and IPSCs (sIPSCs) in layer 6 pyramidal neurons, recording
pipettes (3.0–4.0 MΩ) were filled with an internal solution
containing (in mM) 120 CsMeSO4, 15 CsCl, 10 TEA-Cl, 8 NaCl,
10 HEPES, 0.25 EGTA 5QX-314-Cl, 4Mg-ATP, and 0.3 Na-GTP
with pH 7.25–7.35, 280–300 mOsm. In the presence of D-AP5
(50 µM), 2-min recording was started after at least 5 min of
stabilization after cell rupture, with −70 mV as the holding
potential for sEPSC measurements. After measuring sEPSCs, the
holding potential was changed to 0 mV, followed by 1–2 min
of stabilization and measurements of sIPSCs for 2 min. The
sEPSC and sIPSC data were used for analysis only when the
membrane capacitance and resistance are similar to the baseline
levels. Data were acquired by Clampex 10.2 (Molecular Devices)
and analyzed by Clampfit 10 (Molecular Devices). Drugs were
purchased from Abcam (TTX), Tocris (NBQX, D-AP5), and
Sigma (picrotoxin).
Immunohistochemistry
For layer thickness measurement, mouse pups at P5 were
deeply anesthetized and decapitated, and brains were removed
and incubated in 4% PFA solution at 4◦C overnight. Fixed
brains were sectioned using Vibratome with 50 µm thickness.
Sections were incubated in citrate buffer (pH 6.0) 95◦C for
20 min to promote heat-induced epitope retrieval. Subsequently,
sections were incubated in 0.1% triton X-100 in PBS (phosphate
buffered saline) with 5% normal donkey serum at room
temperature for 1 h, and incubated with Tbr1 antibodies
(Abcam, ab31940, rabbit, 1:500), Ctip2 antibodies (Abcam,
ab18465, rat, 1:500), and Satb2 antibodies (Abcam, ab51502,
mouse, 1:500) at 4◦C overnight. In the next day, sections were
incubated with anti-rat Alexa-488 (Jackson ImmunoResearch,
1:500), anti-rabbit Alexa-568 (Thermofisher, 1:500), anti-mouse
Alexa-647 (Jackson ImmunoResearch, 1:500), and DAPI
(100 ng/ml) at room temperature for 1 h. Sections were mounted
in Dako fluorescence mounting medium. For the counting of
somatostatin (SST)-, parvalbumin (Pv)-, and vasoactive intestinal
peptide (VIP)-positive interneurons, 3-month-old mice were
transcardially perfused with cold 4% paraformaldehyde (PFA)
solution and post-fixed in 4% PFA solution at 4◦C overnight.
Fixed brains were sectioned using Vibratome with 50 µm
thickness and stained using somatostatin antibodies (Peninsula,
T-4547, rabbit, 1:500), parvalbumin antibodies (Sigma-Aldrich,
MAB1572, mouse, 1:500), and VIP antibodies (ImmunoStar,
20077, rabbit, 1:500). Mounted sections were imaged using a
Zeiss LSM 780 confocal microscope. For measurements of the
thickness of cortical layers, a 63×/1.4 oil-immersion objective
was used to image seven consecutive optical sections, and
a maximum-intensity-projected image was analyzed using
ImageJ. For interneuronal counting, a 20×/0.8 air objective
was used to image nine consecutive optical sections, and a
z-stacked image was analyzed using 3D object counter plugin
of ImageJ.
Behavioral Assays
All mouse behavioral essays were performed by an experimenter
blinded to group-identifying information, and behavioral data
were analyzed using EthoVision XT 10 (Noldus), unless indicated
otherwise. At least 24-h-long rest periods were given between
tests. Behavioral tests were performed in order starting from
passive tests, such as measuring home-cage activities, to more
stressful tests. Animals were handled for 10 min per day for
up to 5 days prior to beginning the battery of behavioral
assays so as to reduce stress and anxiety during behavior
caused by an experimenter. On each day of a behavioral test,
all animals were habituated to a dark room under conditions
identical to those of the testing room for 30 min before starting
the test.
Laboras Test
The Laboratory Animal Behavioral Observation Registration and
Analysis System (LABORAS, Metris) was used for long-term
monitoring of mouse movements in Laboras cages, conditions
similar to those of home cages (Quinn et al., 2003). Mice were
individually placed in a single cage within the LABORAS system,
and their activities were recorded for 72 consecutive hours.
Locomotion, rearing, and self-grooming were measured and
automatically analyzed as previously described (Jung et al., 2018;
Yoo et al., 2018).
Open-Field Test
Animals were placed in a white acryl box (40× 40× 40 cm) and
video-recorded for 60 min. Light intensity was set to 120 lux. The
‘‘center’’ region was defined as a 20× 20 cm square in the middle
of the arena.
Light-Dark Test
The apparatus used for the light-dark test consists of two separate
chambers (Light, 21 × 29 × 20 cm; Dark, 21 × 13 × 20 cm)
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as previously described (Jung et al., 2018). The light chamber
was illuminated at 180 lux. The time spent in each chamber
was measured.
Elevated Plus-Maze Test
Animals were placed in the center region of a plus-arm maze
with two open (5 × 30 × 0.5 cm) and closed (5 × 30 × 30 cm)
arms. The maze was elevated to a height of 75 cm from the floor.
Time spent in open or closed arms and total distance moved
were measured.
Three-Chamber Test
Social approach and social novelty recognition were assessed
by performing three-chamber test (Moy et al., 2004; Silverman
et al., 2010) as described previously (Jung et al., 2018; Yoo
et al., 2018). Briefly, the apparatus (60 × 40 × 20 cm)
consists of three compartments; two side chambers have small
containers for either a stranger mouse or a novel object.
The subject mouse was placed in the apparatus, leaving the
small containers in both compartments empty, and then was
allowed to habituate for 10 min. Stranger mouse 1 (129/SvJae
strain) was then placed in the container in one side chamber,
and a novel object was placed in the container in the other
side chamber. The subject mouse was allowed to freely move
around the apparatus for 10 min. Social preference towards
a new stranger over a familiar stranger was assessed by
replacing the object with Stranger mouse 2 (129/SvJae strain)
and recording exploration of targets by the mouse for an
additional 10 min.
Dyadic Social Interaction
A direct social-interaction protocol employing a gray Plexiglas
box (30 × 30 × 30 cm) was performed to measure social
interaction between age-, sex-, and genotype-matched mouse
pairs. Briefly, on day 1, each mouse was habituated to the testing
conditions by allowing it to freely move around the Plexiglas
box for 20 min. On day 2, pairs of unfamiliar age-, genotype-,
and sex-matched mice were simultaneously placed in the cage.
Mouse behaviors were recorded for 10 min, and the time spent
in direct social contacts, including nose-to-nose contact, nose-
to-tail contact, following, allo-grooming and other body contacts
(Silverman et al., 2010), were analyzed by an experimenter
blinded to group-identifying information.
Pup Ultrasonic Vocalization
Mouse pups at postnatal (P) days P5, P7 and P9 were isolated
from their home cages and placed in an empty cage with
bedding. The cage was subsequently placed in a soundproof
chamber, and ultrasonic vocalizations (USVs) were recorded for
5 min using an ultrasound microphone (Avisoft Bioacoustics).
For analysis, spectrograms with a Fourier transformation length
of 256, temporal resolution overlap of 75%, and lower cut-off
frequency of 25 kHz were generated using Avisoft SASLab
Pro software.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism 7. The
normality of data distributions was tested using a D’Agostino and
Pearson normality test. Normally distributed data were analyzed
using Student’s t-test, whereas non-normally distributed data
were analyzed using the non-parametric Mann–Whitney test.
Differences were considered significant at p-values < 0.05.
Results are presented as means ± SE. Statistical details are
described in Supplementary Table S2.
RESULTS
The TBR1-K228E Mutation Inhibits
TBR1 Binding to DNA
A previous study on the crystal structure of the T-box domain in
complex with DNA from the Brachyury transcription factor in
Xenopus indicated that the K228 residue in the T-box domain is
in direct contact with the DNA backbone (Müller andHerrmann,
1997), and homologymodeling of three TBR1mutations (K389E,
W271R and W271C) have been performed (den Hoed et al.,
2018). However, the impact of the TBR1-K228E mutation on
TBR1-DNA interactions and/or the stability of the core structure
of the T-box domain have not been tested by homologymodeling
or binding experiments.
We thus first attempted molecular modeling of the T-box
domain of human TBR1 using the reported crystal structure of
the T-box domain of the DNA-free form of human TBX5 and
human TBX3 in complex with DNA to predict potential
impacts of the TBR1-K228E mutation. These analyses showed
that the TBR1-K228E mutation, which replaces a positively
charged lysine with a negatively charged glutamate, induces
strong repulsion between the glutamate residue and the adjacent
phosphodiester backbone of DNA (Figures 1A,B).
Tomore quantitatively analyze the reduction in DNA binding
of TBR1-K228E, we purified the recombinant T-box domain
(aa 200–400) of human wild-type (WT) TBR1 and TBR1-K228E
proteins. For comparison, we also generated TBR1-N374H,
another TBR1-mutant protein containing an ASD-risk mutation
(Neale et al., 2012).
The CD spectra of purified T-box domains of WT-TBR1,
TBR1-K228E, and TBR1-N374H indicated that both K228E
and N374H mutations altered the conformation and secondary
structural composition to a certain degree, although the presence
of strong negative peaks at ∼210 nm in all purified proteins
indicated that secondary structures, including α-helices and β-
sheets, were largely conserved (Figure 1C). In addition, normal
mode analysis predicted that both K228E and N374H mutations
increased the structural stability of the T-box domain compared
with that of the WT protein (Figure 1D).
To directly and quantitatively measure the DNA-binding
properties of the mutant T-box proteins, we performed
BLI, in which a biotinylated Grin2b-promoter probe was
immobilized on a streptavidin sensor chip, after which
purified T-box proteins were applied as mobile analytes and
the kinetics of association and dissociation were measured
(Figure 1E). These analyses indicated that the K228E mutation
caused a strong (∼3-fold) decrease in the affinity of the
TBR1-K228E protein for DNA, as indicated by an increase
in the Kd value, whereas the N374H mutation had no
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FIGURE 1 | Molecular modeling and measurement of structural stability and DNA-binding affinity of the TBR1-K228E protein. (A) Diagram depicting the location of
K228E and N374H mutations in the T-box domain of the TBR1 protein. (B) Molecular modeling of the TBR1-K228E protein based on the known structure of a
complex of the TBR1 T-box domain with DNA. The indicated TBR1-K228E mutation, which converts a positively charged lysine residue (blue) to a negatively charged
glutamate residue (red) in a region very close to the phosphodiester backbone of the DNA, likely induces repulsion between the protein and DNA. (C) Circular
dichroism (CD) profiles of purified TBR1 T-box proteins (WT, K228E, and N374H). Note that the strong negative peaks at ∼210 nm indicate that the secondary
structures of TBR1 T-box proteins (WT, K228E, and N374H) are largely conserved. (D) Prediction of the stability of TBR1 T-box domains (WT, K228E, and N374H) by
energy-minimization calculations. Note that both K228E and N374H mutations increase structural stability. (E–G) Binding analysis of WT and mutant (K228E and
N374H) TBR1 T-box proteins to the Grin2b-promoter probe using biolayer interferometry (BLI). The biotinylated Grin2b-promoter probe was immobilized on a
streptavidin sensor chip, and TBR1 T-box proteins were applied in the mobile phase. The dotted lines, representing fits of the raw data (solid lines), were used to
obtain Kd, Kon, and Koff values. Note the decreased DNA binding by the TBR1-K228E protein, but not the TBR1-N374H protein, compared with WT-TBR1 protein,
as indicated by Kd and Kon/off values. n = 3 for WT, K228E, and N274H, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ns, not significant, one-way analysis of variance
(ANOVA) with Tukey’s test, #P < 0.05, Student’s t-test.
effect (Figure 1F). This decrease in the Grin2b promoter-
binding affinity of the TBR1-K228E protein was associated
with a ∼2-fold increase in Kon but did not involve a
significant change in Koff (Figure 1G), indicating that the
mutation has a greater effect on the association rate than the
dissociation rate.
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TBR1-K228E Mice Show Increased
TBR1 Protein Levels
To determine the in vivo impacts of the TBR1-K228E
mutation, we generated a knock-in (KI) mouse line carrying
the TBR1-K228E mutation (Figures 2A,B). Heterozygous
and homozygous Tbr1-KI mutant mice—Tbr1+/K228E and
Tbr1K228E/K228E, respectively—were genotyped by genomic PCR
(Figure 2B). Tbr1+/K228E mice were born at normal Mendelian
ratios, although Tbr1K228E/K228E mice could not be detected at
the time of genotyping (∼P7), similar to the neonatal lethality
observed in Tbr1-null mice (Hevner et al., 2001).
Intriguingly, whole-brain levels of TBR1 protein were strongly
increased in both Tbr1+/K228E (∼2-fold) and Tbr1K228E/K228E
(∼6-fold) mice (Figures 2C,D), in line with the previously
reported ∼2-fold increase in the stability of the TBR1-K228E
protein in heterologous cells (den Hoed et al., 2018). RNA-Seq
analyses further showed that this increase in TBR1 protein levels
was likely attributable to an increase in the levels of the Tbr1
transcript (see below).
The TBR1-K228E Mutation Alters Gene
Transcripts Related to Cortical
Development
TBR1 is a transcription factor that acts as both a transcriptional
activator and repressor (Hsueh et al., 2000; Han et al., 2011).
To determine the impacts of the TBR1-K228E mutation on
the transcriptomic profile in the developing mouse brain, we
performed RNA-Seq analysis using forebrain samples from WT,
Tbr1+/K228E, and Tbr1K228E/K228E mice at E16.5, a stage in
brain development with strong Tbr1 expression (Bulfone et al.,
1995). Both Tbr1+/K228E and Tbr1K228E/K228E mice were used
in RNA-Seq analysis to test potential gene dosage effects on
certain transcripts.
RNA-seq analyses showed that only five genes—CRX
and ILK (upregulated), and LMBRD1, LYPD6, and PDE3B
(downregulated)—were differentially expressed between
forebrain samples from Tbr1+/K228E and WT mice at
E16.5 (adjusted p-value < 0.05), as shown by volcano
plots (Figure 3A; Supplementary Table S1). In contrast,
homozygous Tbr1K228E/K228E brains displayed a relatively
large number (111) of differentially expressed genes (DEGs)
relative to WT mice, of which 44 were upregulated and 67 were
downregulated (Figure 3A). qRT-PCR experiments further
indicated the upregulation of Tbr1 and downregulation of
Reln in Tbr1K228E/K228E brains (Supplementary Figure S1).
However, other genes, including the five genes from Tbr1+/K228E
mice, could not be validated, although the directions of the
changes were similar to those observed in RNA-Seq analyses,
which might reflect the small changes in the expression of these
genes or the higher sensitivity of the RNA-Seq analyses over
qRT-PCR analyses.
The top 20 downregulated DEGs among the 111 total DEGs
were identified as frequent downstream targets of Tbr1 or
genes that are associated with brain development (Figure 3B).
One such gene was Wnt7b (Figure 3B), a direct target of
Tbr1 (Huang et al., 2014; Chuang et al., 2015; Fazel Darbandi
et al., 2018) that belongs to the Wnt family of secreted
signaling proteins known to regulate the development and
function of neurons and synapses (Budnik and Salinas, 2011;
Mulligan and Cheyette, 2012; Stamatakou and Salinas, 2014).
Also identified were Reln, a high-risk ASD gene and a direct
target of Tbr1 that encodes a secreted large glycoprotein that
regulates cortical development and neuronal migration (Hsueh
et al., 2000; Hevner et al., 2001); Lypd6, which promotes
Wnt signaling through Lrp6 phosphorylation (Ozhan et al.,
2013) and calcium conductance in SST-positive interneurons
during cortical development (Darvas et al., 2009); and Bcl6,
a direct target of Tbr1 (Bedogni et al., 2010; Fazel Darbandi
et al., 2018) and marker for the embryonic frontal cortex that
functions as a transcriptional repressor to promote neurogenesis
by repressing Notch targets (Tiberi et al., 2012; Chiang and Ihrie,
2014). These results suggest that the TBR1-K228E mutation
downregulates Tbr1 target genes that are known to be involved
in cortical development.
In addition to downregulated DEGs, the 20 upregulated DEGs
were also associated with specific functions. One of the most
strongly upregulated genes was 521 Tbr1 (Figure 3B), in line
with the increased levels of TBR1 protein in Tbr1+/K228E and
522 Tbr1K228E/K228E mice (Figures 2C,D). Other upregulated
DEGs included the genes Nrgn and Cacna2d1, encoding proteins
associated with neuronal synapses. Nrgn, a putative downstream
target of Tbr1 (Huang et al., 2014; Chuang et al., 2015; Fazel
Darbandi et al., 2018), encodes neurogranin, a postsynaptic
protein kinase substrate that sets the response threshold to
calcium influxes (Gerendasy and Sutcliffe, 1997). Cacna2d1
encodes alpha-2/delta-1, a voltage-dependent calcium channel
subunit that mediates the analgesic action of pregabalin and
gabapentin (Field et al., 2006; Xiao et al., 2007) and promotes
astrocyte-induced synapse formation (Eroglu et al., 2009; Chung
et al., 2015; Geisler et al., 2015).
A DAVID GO analysis using the 111 DEGs from
Tbr1K228E/K228E mice revealed two significant terms,
proteinaceous extracellular matrix (ECM) and extracellular
region (adjust p-value < 0.05), as Cellular Components
properties of David GO terms (Figure 3C). The GO term
‘‘ECM’’ was associated with the DEGs, ADAMTS18, COL9A1,
WNT7B, NAV2, TNR, CCBE1, RELN, VCAN, ADAMTS3
and NDNF, whereas the GO term ‘‘extracellular region’’ was
associated with the DEGs, ADAMTS18, LYPD6, SORL1, NDNF,
LRPAP1, COL9A1, HSP90B1, WNT7B, BRINP2, SFRP2,
TNR, CCBE1, CEMIP, GDF10, VCAN, RELN, and IGFBP5.
Among these, the six underlined genes (WNT7B, ADAMTS3,
RELN, LYPD6, NDNF, and LRPAP1) were among the top
20 downregulated DEGs (indicated by underlining in Figure 3B).
The ECM has been strongly implicated in the regulation of
neural development and synapse formation, function, and
plasticity (Venstrom and Reichardt, 1993; Dityatev et al., 2010;
Faissner et al., 2010; Wlodarczyk et al., 2011; Frischknecht and
Gundelfinger, 2012; Frischknecht et al., 2014; Song and Dityatev,
2018). Therefore, these findings suggest that a homozygous
TBR1-K228E mutation decreases the expression of ECM-related
genes in mice at E16.5, thereby suppressing neural and
synapse development.
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FIGURE 2 | Generation and basic characterization of Tbr1+/K228E and Tbr1K228E/K228E mice. (A) Tbr1 gene knock-in (KI) strategy. Note that the TBR1-K228E
mutation is located in exon 1 of the Tbr1 gene. (B) PCR genotyping and confirmation of the TBR1-K228E mutation by DNA sequencing in WT, heterozygous
(Tbr1+/K228E), and homozygous (Tbr1K228E/K228E) mice (E16.5). (C,D) Increased levels of TBR1 protein in Tbr1+/K228E and Tbr1K228E/K228E brains compared with that
in WT brains (E17; males and females), determined by immunoblot analysis of TBR1 protein (∼74 kDa) and quantification of TBR1 signals normalized to α-tubulin.
The image shown is an example from male mouse samples. Note that levels of the TBR1-K228E protein are strongly increased in a gene dosage-dependent manner.
n = 6 mice for WT, four mice for Tbr1+/K228E, and six mice for Tbr1K228E/K228E, ∗∗P < 0.01 vs. WT, Mann–Whitney test.
Notably, the 111 DEGs from E16.5 Tbr1K228E/K228E mice
overlapped with substantial fractions of the DEGs identified
by microarray analysis of Tbr1–/– mice (Chuang et al., 2015)
and RNA-Seq analysis of Tbr1-mutant mice carrying a cortical
layer 6-specific homozygous Tbr1 deletion driven by the Ntsr1-
cre driver, which is first expressed at ∼E16.5 (Fazel Darbandi
et al., 2018). Specifically, 17 of the 111 DEGs overlapped with
the previously reported 124 DEGs from microarray analyses
of Tbr1–/– mice at E16.5 (Chuang et al., 2015). In addition,
27 of the 111 DEGs overlapped with the previously reported
178 DEGs from layer 6-specific Tbr1-null mice at P5 (Fazel
Darbandi et al., 2018; Figure 3D). Intriguingly, a total of 12 genes
were found overlapped in all three sets of DEGs, which included
upregulated FLRT3, FST, NRGN, RUNX1T1, and TRHR, and
downregulated BCL6, GDF10, LYPD6, NFE2L3, NFIA, RORB,
and WNT7B.
The DEG analyses on the three Tbr1-mutant mouse lines
(Tbr1K228E/K228E, Tbr1–/– and layer 6 conditional) differ in
multiple aspects, including gene-targeting strategy (knock-in vs.
knockout vs. conditional knockout, respectively), brain regions
used to prepare mRNA samples (forebrain vs. forebrain vs.
cortical layer 6), and developmental stages (E16.5 vs. E16.5 vs.
P5). Therefore, these 17 and 27 genes likely play important
roles in driving Tbr1-mutant phenotypes, both in embryonic
(E16.5) and P5 stages. Notably, six of these 27 genes (TBR1,
WNT7B, BCL6, MC4R, NFE2L3, and NRGN) were identified
by chromatin immunoprecipitation, among other approaches, as
direct or putative targets of Tbr1 in previous studies (Chuang
et al., 2015; Notwell et al., 2016; Fazel Darbandi et al., 2018).
Enrichment of Tbr1+/K228E and
Tbr1K228E/K228E Transcriptomes in Neuron-
and Astrocyte-Related Gene Sets
In addition to the DEG analyses of RNA-Seq results from
Tbr1+/K228E and Tbr1K228E/K228E mice (E16.5), we attempted
a GSEA4 (Subramanian et al., 2005), which does not rely
on a small number of genes that satisfy certain arbitrary
cut-off parameters, such as p-values or fold changes. Instead,
GSEA uses the entire list of genes ranked according to a
certain parameter (i.e., fold change or p-value) to evaluate
enrichment for precurated gene sets so as to associate a
transcriptome with specific biological functions or pathways in
an unbiased manner.
To gain insights into the impacts of the TBR1-K228E
mutation on gene expression in specific cell types in the
brain, we performed GSEA using cell type-specific gene sets,
including neurons, pyramidal neurons, interneurons, glial cells
(astrocytes, microglia, and oligodendrocytes), and other cell
types (i.e., endothelial and ependymal cells), as previously
described (Jung et al., 2018). The ranked gene list from
heterozygous Tbr1+/K228E mice at E16.5, hereafter termed the
Tbr1+/K228E transcriptome, was negatively enriched for gene sets
associated with pyramidal neurons, interneurons, and astrocytes
(Figure 4A), suggesting underdevelopment of these cell types
in Tbr1+/K228E embryos at E16.5, consistent with globally
suppressed neuroglial development.
4http://software.broadinstitute.org/gsea/
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FIGURE 3 | Analysis of differentially expressed genes (DEGs) from Tbr1+/K228E and Tbr1K228E/K228E mice at E16.5. (A) Volcano plots showing DEGs from
Tbr1+/K228E and Tbr1K228E/K228E brains (E16.5) relative to WT mouse brains. Names of the DEGs from Tbr1+/K228E mice are indicated in the volcano plot, with the
three DEGs shared in Tbr1+/K228E and Tbr1K228E/K228E mice indicated in bold; DEGs from Tbr1K228E/K228E mice are indicated in the panel (B). n = 5 mice for WT,
Tbr1+/K228E, and Tbr1K228E/K228E, false discovery rate (FDR) < 0.05 (orange); FDR < 0.05 and |log2FC| > 1 (red). (B) List of the top 40 DEGs (20 up- and
20 downregulated) in the Tbr1K228E/K228E brain (E16.5; forebrain). FC, fold change. The underlined gene names indicate DEGs associated with the extracellular matrix
(ECM) or extracellular region—the two strongest gene ontology (GO) terms identified in DAVID analyses (see panel C). (C) David GO analysis of the 111 DEGs from
the Tbr1K228E/K228E brain (E16.5; adjusted p-value < 0.05). Note that significant GO terms were found in the Cellular Component domain, but not in Molecular
Function or Biological Process domains. *Adjusted p-value < 0.05; ∗∗adjusted p-value < 0.01. (D) Venn diagram showing the overlap between the 111 DEGs from
the Tbr1K228E/K228E brain at E16.5 and the previously reported 124 DEGs from microarray analyses of the Tbr1–/– forebrain at E16.5 (Chuang et al., 2015) and
178 DEGs from mice carrying a layer 6-specific homozygous Tbr1 deletion (Fazel Darbandi et al., 2018). Note that nearly all up- and downregulated DEGs (red and
green, respectively) in the Tbr1K228E/K228E brain showed up- and downregulation similar to those of the previous results, with the exception of Tbr1, which was
upregulated (not downregulated) in the present study. There were no significant associations between the three different groups by Fisher analysis (see
Supplementary Table S2 for details).
Notably, GSEA patterns in the homozygous Tbr1K228E/K228E
brain (E16.5) differed from those in the Tbr1+/K228E brain.
Specifically, the Tbr1K228E/K228E transcriptome was negatively
enriched for gene sets associated with astrocytes to a greater
extent than that for the Tbr1+/K228E transcriptome. In contrast,
the Tbr1K228E/K228E transcriptome was positively (not negatively)
enriched for gene sets associated with neurons generally and
CA1 pyramidal neurons specifically (Figure 4A). In addition,
the Tbr1K228E/K228E transcriptome was negatively enriched for
gene sets associated with non-neural cells, such as microglia,
ependymal cells, endothelial cells, and mural cells.
Thus, the Tbr1K228E/K228E transcriptome is similar to
the Tbr1+/K228E transcriptome with respect to the negative
enrichment for astrocyte gene sets but differs from the
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FIGURE 4 | Gene Set Enrichment Analysis (GSEA) of transcriptomes from Tbr1+/K228E and Tbr1K228E/K228E mice at E16.5. (A) Negative and dosage-dependent
enrichment of Tbr1+/K228E and Tbr1K228E/K228E transcriptomes in the brain at E16.5 for astrocyte-related gene sets, but distinct enrichments of these lists for gene
sets associated with neurons (pyramidal and interneuronal) and other cell types (ependymal, endothelial, and mural). Dot plots were drawn using normalized
enrichment score (NES; color of circle) and false detection rate (FDR; intensity of circle) from GSEA results using a one-sided, weighted Smirnov–Kolmogorov test.
FDR is the estimated probability that a gene set with a given NES represents a false-positive finding. n = 5 mice for WT, HT (heterozygous), and HM (homozygous),
FDR < 0.05 (see Supplementary Table S1 for details). (B–D) Positive and inverse dosage-dependence of Tbr1+/K228E and Tbr1K228E/K228E transcriptomes (E16.5)
for ribosome-related gene sets, but negative and distinct enrichment of the Tbr1+/K228E transcriptome for synapse-related gene sets and the Tbr1K228E/K228E
transcriptome for ECM-related gene sets. GSEA was performed using precurated GO gene sets in Biological Function (B), Cellular Component (C), and Molecular
Function (D) domains in the C5 category. The top 4–6 gene sets in each GO domain are indicated. n = 5 mice for WT, HT (heterozygous), and HM (homozygous),
FDR < 0.05 (see Supplementary Table S1 for details). (E) Negative enrichment of the Tbr1+/K228E transcriptome for ASD-related gene sets, but no or opposite
enrichment of the Tbr1K228E/K228E transcriptome for ASD-related gene sets. Note that the Tbr1+/K228E transcriptome, but not the Tbr1K228E/K228E transcriptome, also
shows enrichment for bipolar disease- and schizophrenia-related gene sets. n = 5 mice for WT, HT (heterozygous), and HM (homozygous), FDR < 0.05 (see
Supplementary Table S1 for details).
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Tbr1+/K228E transcriptome in that it is positively enriched
for neuron-related gene sets and negatively enriched for
other cell type-related gene sets. These differences between
heterozygous and homozygous TBR1-K228E mutations reveal
both gene dosage-dependent and -independent effects on
gene expression.
Enrichment of Tbr1+/K228E and
Tbr1K228E/K228E Transcriptomes in
Ribosome-, Synapse- and ECM-Related
Gene Sets
To gain insight into the impacts of heterozygous and
homozygous Tbr1 deletion on the transcription of genes
associated with biological pathways and cellular and molecular
functions, we performed GSEA using gene sets in the C5 GO
category. Intriguingly, the Tbr1+/K228E transcriptome (E16.5)
was strongly and positively enriched for multiple ribosome-
related gene sets in Biological Process, Cellular Component,
and Molecular Function domains (Figures 4B–D). The
Tbr1K228E/K228E transcriptome was also positively enriched
for ribosome-related gene sets, although to a lesser extent than
that of the Tbr1+/K228E transcriptome. These results suggest the
possibility that a Tbr1 deletion might drive stronger protein
translation, although this tendency is weaker in the case of
the homozygous mutation, indicative of an inverse gene dosage
effect. The stronger enrichment of theTbr1+/K228E transcriptome
for ribosome-related gene sets relative to the Tbr1K228E/K228E
transcriptomes contrasts with the fewer number of DEGs in the
Tbr1+/K228E transcriptome, suggesting the usefulness of GSEA
using the whole transcriptome in cases where the numbers of
DEGs are small.
In contrast to its positive enrichment for ribosome-related
gene sets, the Tbr1+/K228E transcriptome was negatively
enriched for synapse-related gene sets, including presynaptic
structures and functions and ligand-gated ion channels
(Figure 4C). The Tbr1K228E/K228E transcriptome, however,
was not negatively enriched for synapse-related gene sets but
did show negative enrichment for gene sets associated with the
ECM (Figures 4B–D), in line with the strong enrichment
of ECM-related GO terms among the 111 DEGs from
Tbr1K228E/K228E mice (Figure 3C). Collectively, these findings
suggest that heterozygous and homozygous Tbr1 deletions
strongly and similarly promote expression of ribosome-related
genes, but distinctly suppress expression of synapse- and
ECM-related genes, respectively.
Enrichment of ASD-Related Gene Sets
Among Tbr1+/K228E and Tbr1K228E/K228E
Transcriptomes
TBR1 is a high-risk ASD gene and has been shown to affect the
expression of many other ASD-risk genes (Neale et al., 2012;
O’Roak et al., 2012, 2014; Traylor et al., 2012; De Rubeis et al.,
2014; Deriziotis et al., 2014; Hamdan et al., 2014; Palumbo et al.,
2014; Chuang et al., 2015; Sanders et al., 2015; Notwell et al., 2016;
Bowling et al., 2017; Geisheker et al., 2017; Fazel Darbandi et al.,
2018; McDermott et al., 2018; Vegas et al., 2018). We thus tested
whether the Tbr1+/K228E and Tbr1K228E/K228E transcriptomes are
enriched for ASD-related gene sets (Werling et al., 2016). We
also assessed gene sets associated with other neurological and
psychiatric brain disorders.
The Tbr1+/K228E transcriptome (E16.5) was negatively and
strongly enriched for multiple ASD-related gene sets, including
DEG Down Voineagu and Co-Exp Down, M12 Voineagu,
SFARI genes, ASD_AUTISMKB, De Novo Variants, De Novo
Missense, and FMRP Targets, whereas no enrichment was
observed for gene sets upregulated in ASD (DEG Up Voineagu
and Co-Exp Up, M16 Voineagu; Figure 4E). In addition, the
Tbr1+/K228E transcriptome was enriched for gene sets associated
with bipolar disorder and schizophrenia, but not for gene sets
associated with other brain disorders. These results suggest
that the Tbr1+/K228E transcriptome (E16.5) strongly mimics the
transcriptomic pattern of ASD.
The transcriptome from homozygous Tbr1K228E/K228E mice
(E16.5), however, showed little enrichment for ASD-related
gene sets (Figure 4E). Instead, it was negatively enriched for
gene sets upregulated in ASD (DEG Up Voineagu and Co-Exp
Up, M16 Voineagu), a pattern opposite that observed in ASD.
Moreover, the Tbr1K228E/K228E transcriptome was positively
enriched for the FMRP targets gene set; again, an enrichment
pattern opposite that observed in ASD.
These results collectively suggest that the Tbr1+/K228E
transcriptome strongly mimics the transcriptomic changes
observed in ASD, whereas the Tbr1K228E/K228E transcriptome
does not, suggesting the possibility of compensatory changes in
the context of the stronger homozygous TBR1-K228E mutation.
Altered Numbers of Parvalbumin-Positive
Neurons in Superficial and Deep Cortical
Layers of the Tbr1+/K228E mPFC
TBR1 is a critical regulator of cortical development (Bulfone
et al., 1995, 1998; Dwyer and O’Leary, 2001; Hevner et al., 2001,
2002; Englund et al., 2005; Kolk et al., 2006; Bayatti et al., 2008;
Han et al., 2011; McKenna et al., 2011; Cánovas et al., 2015;
Marinaro et al., 2017; Elsen et al., 2018; Liu et al., 2018). We
thus assessed possible impairments in various aspects of cortical
development, including cortical thickness, layer organization and
cellular distribution in the Tbr1+/K228E brain.
We first measured the thickness and layer distribution of
the neocortex in the prelimbic region of the medial prefrontal
cortex (mPFC) in Tbr1+/K228E mice at P5, a developmental
stage at which neurons in different cortical layers can be
readily visualized by immunostaining. There was no statistically
significant difference in the thickness of the cortex as a whole
or of individual cortical layers (L2/3, L5, and L6) between
WT and Tbr1+/K228E mice, visualized by immunofluorescence
staining for specific layers [SatB2, mainly layer 2/3; Ctip2,
layer 5/6 (weakly for 6); TBR1, layer 6; Figures 5A–C;
Supplementary Figure S2].
We next counted SST-, Pv-, and VIP-positive GABAergic
interneurons across the depth of the cortex at 3 months, the
developmental stage at which we performed electrophysiological
and behavioral experiments (see below). These counts
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FIGURE 5 | Altered numbers of parvalbumin (Pv)-positive interneurons in superficial and deep cortical layers, but normal cortical thickness in the Tbr1+/K228E
mPFC. (A–C) Normal thickness of the whole cortex and individual cortical layers in the prelimbic region of the mPFC in Tbr1+/K228E (HT) mice (P5), as indicated by
the thickness of total (C) and individual (B) cortical layers. Layers were marked by immunofluorescence staining: layer2/3, SatB2; layer 5/6, Ctip2; and layer 6, TBR1.
n = 3 sections from three mice, ns, not significant, Mann–Whitney test. Scale bar, 100 µm. (D–G) Normal total number of somatostatin (SST)-positive neurons in the
prelimbic region of the mPFC of Tbr1+/K228E mice (HT; 3 months), as indicated by the number of SST-positive cells across the total cortical depth (bin 1–10; lower
numbers correspond to upper layers) and the sum of superficial and deep cortical layers (bins 1–5 and 6–10 for superficial and deep layers, respectively).
n = 12 sections from three mice for WT and HT, ns, not significant, two-way ANOVA with Sidak’s multiple comparison test (for SST-positive cells in superficial or deep
layer) and Student’s t-test (total SST-positive cells). Scale bar, 100 µm. (H–K) Decreased numbers of Pv-positive neurons in superficial layers and increased numbers
in deep cortical layers in the prelimbic region of the mPFC of Tbr1+/K228E (HT) mice (3 months). n = 12 sections from three mice for WT and HT, ∗P < 0.05, ns, not
significant, two-way ANOVA with Sidak’s multiple comparison test (for PV-positive cells in superficial or deep layers) and Student’s t-test (total PV-positive cells).
Scale bar, 100 µm. (L–O) Normal total number of vasoactive intestinal peptide (VIP)-positive neurons in the prelimbic region of the mPFC of Tbr1+/K228E (HT) mice
(3 months), as indicated by the number of VIP-positive cells across the total cortical depth. n = 12 sections from three mice for WT and HT, ns, not significant,
two-way ANOVA with Sidak’s multiple comparison test (for VIP-positive cells in superficial or deep layer) and Student’s t-test (total VIP-positive cells). Scale bar,
100 µm.
revealed no differences in the total numbers of SST-, Pv-,
or VIP-positive interneurons between WT and Tbr1+/K228E
mice (Figures 5E,I,M). Intriguingly, however, the number
of Pv-positive interneurons in superficial cortical layers was
decreased, whereas that in the deep layers was increased
(Figures 5J,K). Although SST- and VIP-positive neurons
showed a similar trend toward reciprocal changes in superficial
and deep layers, these differences did not reach statistical
significance (Figures 5F,G,N,O).
These results collectively suggest that the heterozygous
TBR1-K228E mutation does not affect the thickness of the whole
cortex or individual cortical layers, but does affect the number of
Pv-positive interneurons in both superficial (decreased) and deep
(increased) cortical layers.
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Increased Inhibitory Synaptic Transmission
in Cortical Layer 6 Pyramidal Neurons
The increased number of Pv-positive interneurons in cortical
layer 6 in the Tbr1+/K228E brain points to the possibility of altered
synaptic transmission in layer 6 pyramidal neurons. Accordingly,
we next measured excitatory and inhibitory transmission in these
neurons; we also measured neuronal excitability, a property that
bidirectionally impacts synaptic transmission.
To this end, we first measured mEPSCs in layer 6 pyramidal
neurons in the prelimbic region of the mPFC in WT and
Tbr1+/K228E brains (11–12 weeks). We used young adult
mice for these experiments to allow direct comparisons with
electrophysiological and behavioral experiments performed in
mice of this age (see below).
There were no differences in the frequency or amplitude
of mEPSCs between genotypes (Figure 6A). In contrast,
there was a significant increase in the frequency, but not
amplitude, of mIPSCs in Tbr1+/K228E layer 6 pyramidal
neurons (Figure 6B). These results suggest that inhibitory,
but not excitatory, synaptic transmission onto mPFC layer
6 pyramidal neurons were selectively increased by a heterozygous
TBR1-K228E mutation.
Because network activities often affect excitatory and
inhibitory synaptic transmission, we next measured sEPSCs and
sIPSCs in Tbr1+/K228E mPFC layer 6 pyramidal neurons in
the absence of tetrodotoxin to allow AP firings. Intriguingly,
there was an increase in the frequency, but not amplitude, of
sEPSCs (Figure 6C), a finding that contrasts with the normal
frequency of mEPSCs. The frequency, but not amplitude, of
sIPSCs was also increased in these mutant neurons (Figure 6D),
similar to the observed increased mIPSC frequency. These
results suggest that network activity has no effect on increased
inhibitory synaptic transmission, but induces an increase in the
frequency of excitatory synaptic transmission, an effect that likely
serves to normalize the balance between synaptic excitation and
inhibition (E/I balance).
Lastly, we measured neuronal excitability in Tbr1+/K228E
mPFC layer 6 pyramidal neurons. We found no difference
in the excitability of Tbr1+/K228E neurons between genotypes,
as shown by the current-firing curve, input resistance, and
AP threshold (Figures 6E–G).
These results collectively suggest that the heterozygous
TBR1-K228E mutation leads to an abnormal increase in
inhibitory synaptic transmission in layer 6 pyramidal neurons
without affecting excitatory synaptic transmission or neuronal
excitability. This change (increased inhibitory transmission) in
the presence of network activity leads to an increase in excitatory
transmission, a compensatory change that likely acts to maintain
a normal synaptic E/I balance.
ASD-Like Social Deficits, Increased
Repetitive Behaviors, Altered Anxiety-Like
Behavior, and Modestly Increased
Locomotion in Tbr1+/K228E Mice
Because Tbr1 is strongly associated with ASD (Bedogni et al.,
2010; Neale et al., 2012; O’Roak et al., 2012, 2014; Traylor et al.,
2012; De Rubeis et al., 2014; Deriziotis et al., 2014; Hamdan et al.,
2014; Palumbo et al., 2014; Chuang et al., 2015; Sanders et al.,
2015; Bowling et al., 2017; Geisheker et al., 2017; McDermott
et al., 2018; Vegas et al., 2018), we subjected Tbr1+/K228E mice
first to ASD-related behavioral tests.
In the three-chamber test for social interaction (Crawley,
2004; Moy et al., 2009; Silverman et al., 2010), Tbr1+/K228E
mice (3 months; male) exhibited normal social approach
and social novelty recognition, as shown by the time spent
exploring social or object targets and the social preference index
(Figure 7A). However, Tbr1+/K228E mice exhibited reduced
social interaction in direct social-interaction tests, as shown by
the total time spent in social interaction (Figure 7B). Upon
separation from their mothers, Tbr1+/K228E pups (P5–9; male
and female) showed normal levels of social communication
by USVs, a measure of social communication in rodents
(Scattoni et al., 2009; Burgdorf et al., 2011; Wöhr and
Schwarting, 2013; Portfors and Perkel, 2014), as indicated by
the number of emitted USVs and the latency to the first
USV call (Figure 7C). These results are suggestive of normal
levels of anxiety-like behaviors and social communication in
Tbr1+/K228E mice.
In tests for repetitive behaviors using Laboras cages, in
which mouse movements were monitored for 72 consecutive
hours, Tbr1+/K228E mice showed modestly increased repetitive
self-grooming during the light-off period, but not during
the light-on period (Figure 7D). Measurements of rearing, a
form of exploratory behavior, in Laboras cages, revealed a
significant increase in Tbr1+/K228E mice during the light-off
period, but not during the light-on period (Figure 7E). These
results suggest increased repetitive self-grooming and rearing in
Tbr1+/K228E mice.
Finally, given that ASD is associated with anxiety
and attention-deficit/hyperactivity disorder (ADHD)-like
hyperactivity, wemeasured anxiety-like and locomotor behaviors
in Tbr1+/K228E mice. In the elevated plus-maze test, Tbr1+/K228E
mice spent more time in closed arms, but less time in open arms
(Figure 8A), indicative of anxiety-like behavior. In addition,
Tbr1+/K228E mice spent less time in the light chamber in the
light-dark test (Figure 8B), further indicative of anxiety-like
behavior. These results suggest that Tbr1+/K228E mice show
increases in anxiety-like behaviors.
In the open-field test, Tbr1+/K228E mice showed normal levels
of locomotor activity (Figure 8C). Notably, Tbr1+/K228E mice
spent an increased amount of time in the center, indicative
of anxiolytic-like behavior. However, Tbr1+/K228E mice also
showed reduced habituation to the novel open-field environment
(Figure 8C), which is known to involve anxiety (Bailey and
Crawley, 2009; Campbell et al., 2014) and may contribute to the
increased time spent in the center region of the open-field arena.
In Laboras cages, however, Tbr1+/K228E mice showed modest
hyperactivity during the first ∼6 h on day 1 (light-off period),
although total locomotion over 3 days did not change in light-off
or light-on periods (Figure 8D).
Taken together, these results suggest that Tbr1+/K228E mice
display social deficits, repetitive behaviors, altered anxiety-like
behavior, and modestly increased locomotion.
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FIGURE 6 | Increased inhibitory synaptic transmission in cortical layer 6 pyramidal neurons. (A) Normal miniature excitatory postsynaptic current (mEPSC)
frequency and amplitude in layer 6 pyramidal neurons in the prelimbic region of the mPFC of Tbr1+/K228E (HT) mice (11–12 weeks). n = 15 neurons from three mice
for WT and 19 neurons from four mice for HT, ns: not significant, Student’s t-test (mEPSC amplitude), Mann–Whitney test (mEPSC frequency). (B) Increased
frequency but normal amplitude of miniature inhibitory postsynaptic currents (mIPSCs) in layer 6 pyramidal neurons in the prelimbic region of the mPFC of
Tbr1+/K228E (HT) mice (11–12 weeks). n = 17 neurons from three mice for WT and 15 neurons from three mice for HT, ∗P < 0.05, ns: not significant, Mann–Whitney
test (mIPSC amplitude), Student’s t-test (mIPSC frequency). (C) Increased frequency but normal amplitude of spontaneous EPSCs (sEPSCs) in layer 6 pyramidal
neurons in the prelimbic region of the mPFC of Tbr1+/K228E (HT) mice (11–12 weeks). n = 14 neurons from three mice for WT and 12 neurons from three mice for HT,
∗∗P < 0.01, ns: not significant, Mann–Whitney test (sEPSC frequency), Student t-test (sEPSC amplitude). (D) Increased frequency but normal amplitude of
spontaneous IPSCs (sIPSCs) in layer 6 pyramidal neurons in the prelimbic region of the mPFC of Tbr1+/K228E (HT) mice (11–12 weeks). n = 14 neurons from
three mice for WT and 12 neurons from three mice for HT, ∗P < 0.05, ns: not significant, Mann–Whitney test (sIPSC frequency and amplitude). (E–G) Normal
excitability of layer 6 pyramidal neurons in the prelimbic region of the mPFC in Tbr1+/K228E (HT) mice (11–12 weeks), as indicated by current-firing curve (E), input
resistance (F), and action potential (AP) threshold (G). n = 22 neurons from four mice for WT and 17 neurons from four mice for HT, ns: not significant, current-firing
curve: two-way repeated-measures ANOVA with Sidak’s multiple comparisons test, AP threshold: student’s t-test, input resistance: two-way repeated measures
ANOVA with Sidak’s multiple comparisons test.
DISCUSSION
In the current study, we evaluated impacts of the ASD-derived
TBR1-K228E mutation in mice, identifying a multitude of
changes at transcriptomic, protein, cellular, synaptic, and
behavioral levels.
Our molecular modeling data indicate that the TBR1-K228E
mutation leads to a strong change in local charges, from
positive to negative, on the surface of the TBR1 protein near
the region that binds the negatively charged backbone of
target DNA (Figure 1B). While this has a minimal impact on
secondary structures or the structural stability of the protein
(Figures 1C,D), it leads to approximately a 3-fold decrease in
the Kd value for binding of the mutant protein to the Grin2b-
promoter region, reflecting predominantly a decrease in the
dissociation rate (Figures 1E–G). These changes are predicted to
lead to decreased TBR1-dependent regulation of the expression
of target genes.
Interestingly, whole-brain levels of TBR1 protein were
markedly increased in Tbr1+/K228E mice (∼2.5-fold) and
Tbr1K228E/K228E mice (∼6-fold; Figures 2C,D). These increases
are reminiscent of the previous reported increase in the stability
of the TBR1-K228E protein in HEK293 cells (den Hoed
et al., 2018). Given that levels of the Tbr1 transcript were
increased, whereas expression of known Tbr1 target genes such
asWnt7b, Reln, and Bcl6 were decreased in Tbr1K228E/K228E mice
(Figures 3A,B), the increased levels of TBR1 protein likely reflect
a compensatory upregulation of Tbr1 attributable to the limited
binding of the TBR1-K228E protein to target DNAs (Figure 1).
Tbr1+/K228E andTbr1K228E/K228E mice at E16.5 showed altered
transcriptomic profiles relative to WT mice (Figures 3, 4). These
changes may reflect the limited interaction of TBR1-K228E
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FIGURE 7 | Social deficits and repetitive behaviors in Tbr1+/K228E mice. (A) Normal levels of social approach and social novelty recognition in Tbr1+/K228E mice
(3 months; male) in the three-chamber test, as shown by time spent exploring social (S1) vs. object (O) targets for social approach, or old stranger (S1) vs. new
stranger (S2) for social novelty, and the social preference index [i.e., (time spent in sniffing S1 − time spent in O)/total time spent (S1+O) × 100]. n = 9 mouse pairs
for WT and HT (social approach), n = 10 mouse pairs for WT and HT (social novelty), ∗∗∗P < 0.001, two-way ANOVA with Sidak’s test (for S-O or S2-S1
comparisons; multiple comparisons between S-S, S1-S1, or S2-S2 were not performed for the lack of genotype × target interactions), ns: not significant, Student’s
t-test (preference index). (B) Suppressed direct social interaction in Tbr1+/K228E mice (3 months; male), as indicated by time spent in total interaction between age-,
sex- and genotype-matched mouse pairs. n = 9 mouse pairs for WT and HT, ∗∗P < 0.01, ns: not significant, Mann–Whitney test. (C) Normal ultrasonic vocalizations
(USVs) in Tbr1+/K228E pups (P5–9; male and female) separated from their mothers, as indicated by the number of emitted USVs and latency to first USV call.
n = 12 pups (WT-P5), 9 (HT-P5), 15 (WT-P7), 16 (HT-P7), 15 (WT-P9) and 16 (HT-P9; number of calls), n = 12 (WT-P5), 9 (HT-P5), 15 (WT-P7), 15 (HT-P7), 15 (WT-P9)
and 16 (HT-P9; latency to first call), ns, not significant, two-way ANOVA with Sidak’s multiple comparisons test. (D,E) Enhanced self-grooming and rearing in
Tbr1+/K228E mice (3 months; male) in Laboras cages, where mouse movements were monitored for 72 consecutive hours without prior habituation. n = 7 mice for
WT and HT, ∗P < 0.05, ∗∗∗P < 0.001, ns: not significant, two-way repeated-measures ANOVA with Sidak’s multiple comparison test and Mann–Whitney test
(light-on/off).
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FIGURE 8 | Altered anxiety-like behavior and modestly increased locomotor activity in Tbr1+/K228E mice. (A) Enhanced anxiety-like behavior in Tbr1+/K228E mice
(3 months; male) in the elevated plus-maze test, as shown by time (total and %) spent in open/closed arms. n = 10 mice for WT and HT, ∗P < 0.05, ∗∗P < 0.01,
two-way ANOVA with Sidak’s multiple comparison test (total time) and Mann–Whitney test (% time). (B) Enhanced anxiety-like behavior in Tbr1+/K228E mice
(3 months; male) in the light-dark test, as shown by time spent in the light chamber. n = 10 mice for WT and HT, ∗P < 0.05, Mann–Whitney test. (C) Normal
locomotor activity but decreased habituation in Tbr1+/K228E mice (3 months; male) in the open-field test. Note that the time spent in the center region of the
open-field arena is abnormally increased, indicative of anxiolytic-like behavior, although the suppressed habitation to the environment, indicated by the increasing
difference in the distance moved across the 10-min sections and the distance moved during the first and last 10 mins, might complicate this interpretation.
n = 10 mice for WT and HT, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ns: not significant, repeated measures two-way ANOVA with Dunnett’s multiple comparisons test
(Distance moved over 60 min, Center time over 60 min), Wilcoxon matched-pairs signed-rank test (10 min vs. 60 min), Student’s t-test (total distance moved), and
Mann–Whitney test (total time in center). (D) Modestly increased locomotor activity in Tbr1+/K228E mice (3 months; male) in Laboras cages. Note that hyperactivity is
mainly observed during the first ∼6 h of the light-off period on day 1. n = 7 mice for WT and HT, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, ns: not significant, two-way
repeated-measures ANOVA with Sidak’s multiple comparisons test and Mann–Whitney test (light-on/off).
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protein with FOXP2 (Deriziotis et al., 2014), a transcription
factor critical for brain development that may act together with
TBR1 to regulate gene transcription. In addition, overexpressed
TBR1-K228E protein in excitatory neurons may be normally
targeted to the nucleus, but could form abnormal aggregates
with TBR1 binding partners known to be important for
transcriptional regulation, such as CASK or FOXP2, thereby
inhibiting their functions in the nucleus in a dominant-negative
manner, as observed in HEK293 cells and suggested previously
(Deriziotis et al., 2014).
The genes whose expression was altered in Tbr1+/K228E and
Tbr1K228E/K228E mice at E16.5 were associated with diverse
functions. In particular, genes that were differentially expressed
between Tbr1K228E/K228E and WT mice were strongly associated
with the ECM (Figure 3C). In addition, GSEA results indicated
strong, negative enrichment of ECM-related gene sets in
the Tbr1K228E/K228E transcriptome, but not the Tbr1+/K228E
transcriptome (Figure 4B). These results suggest that the
homozygous TBR1-K228E mutation leads to strong suppression
of the expression of ECM-related genes, which are known to
regulate neural development and synapse formation, function,
and plasticity (Venstrom and Reichardt, 1993; Dityatev et al.,
2010; Faissner et al., 2010; Wlodarczyk et al., 2011; Frischknecht
and Gundelfinger, 2012; Frischknecht et al., 2014; Song and
Dityatev, 2018). Notably, our GSEA data on the Tbr1K228E/K228E
transcriptome indicated that gene sets associated with astrocytes,
microglia, ependymal cells, endothelial cells, and mural cells
were negatively enriched (Figure 4A). Therefore, the limited
expression of ECM-related genes in Tbr1K228E/K228E mice at
E16.5 might be a reflection of suppressed development of
multiple cell types, including astrocytes, in the mutant embryo.
Notably, the negative enrichment for gene sets associated with
astrocytes is at odds with a previous report that TBR1 promotes
neuronal differentiation and suppresses astrocyte formation
in the olfactory bulb (Méndez-Gómez et al., 2011), although
whether TBR1 has a different role in the mPFC remains to
be determined.
DEG and GSEA analyses revealed shared and distinct changes
in Tbr1+/K228E and Tbr1K228E/K228E transcriptomes at E16.5.
However, because such a small number of DEGs were identified
between Tbr1+/K228E and WT mice (five), it was not possible
to make a meaningful quantitative comparison of Tbr1+/K228E
and Tbr1K228E/K228E transcriptomes based on this analysis. In
contrast, GSEA results provided a clear answer to this question.
Specifically, the Tbr1+/K228E and Tbr1K228E/K228E transcriptomes
showed shared negative enrichment for astrocyte-related
gene sets and positive enrichment for ribosome-related gene
sets, although the latter displayed an inverse gene-dosage
effect, unlike the former. In contrast, the Tbr1+/K228E (but
not Tbr1K228E/K228E) transcriptome showed unique, negative
enrichment for gene sets associated with neurons, synapses, and
ASD risk. On the other hand, the Tbr1K228E/K228E transcriptome
(but not theTbr1+/K228E transcriptome) showed unique, negative
enrichment for gene sets associated with specific non-neuroglial
cells (i.e., ependymal and endothelial), the ECM, and ASD.
It is unclear why the Tbr1+/K228E transcriptome is negatively
enriched for neuron/astrocyte-related and synapse-related
gene sets, but positively associated with ribosome-related
gene sets. It is conceivable that the strong suppression of
neuroglia- and synapse-related gene expression might promote
strong compensatory expression of ribosome-related genes,
which are known to be important for neuronal outgrowth
and differentiation of synapses during brain development and
maintenance (Bramham and Wells, 2007; Jung et al., 2012;
Shigeoka et al., 2016), so as to normalize the suppressed neural
development in the Tbr1K228E/K228E brain.
These GSEA results collectively suggest first that heterozygous
and homozygous TBR1-K228E mutations in mice at E16.5 lead
to both shared and distinct changes in transcriptomic profiles.
Perhaps a more interesting observation is that the heterozygous
TBR1-K228E mutation leads to ASD-related transcriptomic
patterns that mimic those observed in ASD, whereas the
homozygous TBR1-K228E mutation leads to transcriptomic
changes opposite to those observed in ASD (Figure 4C). This
highlights the importance of studying heterozygous Tbr1-
mutant mice in exploring ASD-relevant pathophysiological
mechanisms. In this context, the synapse-related gene sets
that were negatively enriched in the Tbr1+/K228E (but not
Tbr1K228E/K228E) transcriptome might contribute to the
development of ASD-related phenotypes, such as abnormal
neuronal projections and development of neural circuits.
These points, however, do not lessen the importance of the
transcriptomic phenotypes shared by Tbr1K228E/K228E and
Tbr1+/K228E mice, such as astrocyte- and ribosome-related
genes, which may be more directly associated with the role of
TBR1 in the regulation of embryonic and cortical development.
One of the most unexpected results in the current study
was the reciprocal change in the density of Pv-positive
interneurons in superficial and deep cortical layers in the
prelimbic region of the mPFC in heterozygous Tbr1+/K228E
mice (Figure 5)—specifically, increased density in deep layers
and decreased density in superficial layers. These changes were
not associated with similar changes in the density of SST-
or VIP-positive interneurons. It has been shown that Tbr1
is primarily expressed in excitatory glutamatergic neurons in
various brain regions, including the neocortex (Hevner et al.,
2001, 2003). Therefore, the altered densities of Pv interneurons
might be associated with certain primary changes occurring
in neocortical glutamatergic neurons. For instance, decreased
activity of layer 6 pyramidal neurons in Tbr1+/K228E mice might
suppress the projection of layer 6 cortical pyramidal neurons
to the thalamus, as reported previously (Hevner et al., 2001,
2002), which would subsequently suppress the thalamocortical
pathways that project to neocortical pyramidal neurons and
interneurons (Delevich et al., 2015), pathways that are known
to be important for the tangential migration of interneurons
from deep to superficial cortical layers in the developing cortex
(Tuncdemir et al., 2016).
Results of electrophysiological analyses of layer 6 pyramidal
neurons (Figure 6) are in line with the increased density
of Pv interneurons in deep cortical layers. Specifically, the
frequency, but not amplitude, of mIPSCs was increased in layer
6 pyramidal neurons in Tbr1+/K228E mice at 2–3 months age,
the developmental stage at which Pv interneuronal densities
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were quantified. This result might indicate that, because of
their increased number, Pv interneurons may provide strong
inhibitory synaptic input onto target layer 6 pyramidal neurons.
Notably, the extent of the increases in mIPSC and sIPSC
frequencies is greater than that in the number of Pv interneurons
in Tbr1+/K228E mice, suggesting the possibility that the increased
mIPSC and sIPSC frequencies might involve increases in
inhibitory synapse formation, presynaptic release at inhibitory
synapses, or the excitability of Pv interneurons. Intriguingly,
network activity increased excitatory synaptic input onto these
pyramidal neurons, an effect that likely serves to normalize the
synaptic E/I balance. Whether this compensation normalizes the
output function of layer 6 pyramidal neurons in brain slices or
in vivo remains to be determined. Pv interneurons have also been
implicated in the regulation of brain oscillations in the gamma
range and cognitive brain functions (Cardin et al., 2009; Sohal
et al., 2009; Cardin, 2016). Therefore, the increased mIPSC and
sEPSC frequencies in the Tbr1+/K228E mPFC might disrupt the
normal functions of Pv interneurons.
Tbr1+/K228E mice showed abnormal behaviors in social,
repetitive behavioral, anxiety, and locomotor domains.
Specifically, these mice showed ASD-like impaired direct
social interaction and increased repetitive behavior, including
self-grooming (Figure 7). In addition, Tbr1+/K228E mice
showed increased anxiety-like behavior (elevated plus-maze
and light-dark tests) and modestly increased locomotor activity
(Laboras test; Figure 8). Determining how the heterozygous
TBR1-K228E mutation leads to these behavioral abnormalities
at the circuit level may take extensive additional investigations.
However, a previous study reported that social deficits can
be induced in WT mice by optogenetically stimulating mPFC
pyramidal neurons and that the resulting social deficits
can be rescued by activation of Pv interneurons (Yizhar
et al., 2011). In addition, Cntnap2-knockout mice, a mouse
model of ASD (Peñagarikano et al., 2011), display pyramidal
neuronal hyperactivity and social deficits that are normalized
by stimulation of Pv interneurons (Selimbeyoglu et al., 2017).
Moreover, mice harboring a neuroligin 3-R351C mutation,
another mouse model of ASD (Tabuchi et al., 2007), display
abnormal gamma oscillations involving Pv interneuronal
hypo-excitability and behavioral deficits that are normalized by
Pv interneuronal stimulation at a gamma frequency (40 Hz)
nested at a theta frequency (8 Hz; Cao et al., 2018). Although
these studies largely implicate decreased functions of Pv
interneurons in the regulation of local brain oscillation and
social interaction, the converse situation involving increased Pv
neuronal density and output, as in our current study, might also
induce functional abnormalities of Pv interneuron networks in
the mPFC.
TBR1 has been strongly linked to ASD (Neale et al., 2012;
O’Roak et al., 2012, 2014; Traylor et al., 2012; Abrahams et al.,
2013; De Rubeis et al., 2014; Deriziotis et al., 2014; Hamdan
et al., 2014; Palumbo et al., 2014; Chuang et al., 2015; Bowling
et al., 2017; Geisheker et al., 2017; McDermott et al., 2018;
Vegas et al., 2018). Perhaps one of the most important results
of our study is that a heterozygous TBR1 point mutation
(TBR1-K228E) from a human ASD patient can actually induce
ASD-like behavioral phenotypes in mice, establishing a causal
relationship and thus prima facie evidence of validity. In addition,
our study provides relevant mechanisms at transcriptomic,
synaptic, and cell biological levels. Specifically, DEG and GSEA
analyses identified genes or gene sets that have been strongly
associated with ASD, including high-risk ASD genes (Abrahams
et al., 2013), genes involved in brain development (Brambilla
et al., 2003; Courchesne et al., 2007; Walsh et al., 2008; Hazlett
et al., 2017), and genes associated with neuronal synapses
(Zoghbi, 2003; Garber, 2007; Südhof, 2008; Bourgeron, 2009;
Spooren et al., 2012; Jiang and Ehlers, 2013; Won et al., 2013;
Ebrahimi-Fakhari and Sahin, 2015; Monteiro and Feng, 2017)
and astrocytes (Clarke and Barres, 2013; Petrelli et al., 2016).
In addition, our study demonstrated that Pv interneurons,
which have been strongly implicated in ASD (Lawrence et al.,
2010; Yizhar et al., 2011; Saunders et al., 2013; Barnes et al.,
2015; Filice et al., 2016; Selimbeyoglu et al., 2017; Cao et al.,
2018; Hashemi et al., 2018; Lee et al., 2018), exhibit an altered
density in Tbr1+/K228E mice. Moreover, the increased inhibitory
synaptic transmission in layer 6 pyramidal neurons supports the
role of an E/I imbalance in ASD (Rubenstein and Merzenich,
2003; Pizzarelli and Cherubini, 2011; Nelson and Valakh, 2015;
Lee et al., 2017).
Lastly, a recent study on mice with a deletion in Tbr1
restricted to cortical layer 6 starting from late gestation
was shown to display various ASD-related phenotypes (Fazel
Darbandi et al., 2018). An RNA-Seq analysis of these mice
showed altered expression of many genes associated with brain
development and ASD risk (Fazel Darbandi et al., 2018),
similar to our results. In addition, these mice showed decreases
in the number of both excitatory and inhibitory synapses
and decreased neuronal excitability, as supported by increased
hyperpolarization-activated cation currents in layer 6 pyramidal
neurons in the somatosensory cortex. These synaptic changes
contrast with the synaptic and neuronal changes observed in
our Tbr1+/K228E mice: increased mIPSC frequency and sEPSC
frequency, but normal excitability of layer 6 pyramidal neurons.
This discrepancy might be attributable to the use of layer
6 pyramidal neurons from different cortical areas (mPFC vs.
somatosensory), deletion of the gene in different brain regions
and cell types (whole-brain vs. layer 6 pyramidal neurons),
and/or introduction of different types of mutations (a point
mutation that increases protein level vs. an exon-deleting
mutation that decreases protein level) in the two studies.
In summary, our study demonstrates that the heterozygous
TBR1-K228E mutation identified in individuals with ASD can
induce ASD-like behavioral phenotypes in mice. In addition, our
study reveals various abnormalities at transcriptomic, protein,
cellular, and synaptic levels that may underlie the behavioral
deficits observed in Tbr1+/K228E mice.
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FIGURE S1 | qRT-PCR analyses for some of the DEGs from Tbr1+/K228E and
Tbr1K228E /K228E mice. (A) qRT-PCR analyses were performed for all five DEGs
from Tbr1+/K228E mice [(E16.5; LMBRD1, LYPD6, PDE3B, ILK, and CRX) and
six DEGs (Tbr1 and six DEGs that are associated with ECM and extracellular GO
terms indicated by underline (Figures 3B,C)] from Tbr1K228E /K228E mice (E16.5).
The genes that are increased and decreased in the expression in RNA-Seq
analyses are indicated by red and blue colors, respectively. n = 5 mice (males and
females mixed) for WT, Tbr1+/K228E, and Tbr1+/K228E, ∗P < 0.05, ∗∗∗P < 0.001,
one-way ANOVA with Dunnett’s test.
FIGURE S2 | Ctip2 marks layer 5 more strongly than layer 6. (A) Ctip2 marks
layer 5 more strongly than layer 6 (lower two images) and, together with Tbr1,
reveals the boundary between layers 5 and 6 (upper two images). The upper two
images were borrowed from Figure 5A for comparison.
TABLE S1 | All RNA-Seq data.
TABLE S2 | Statistical results.
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